Literature DB >> 8141212

Gynecologic manifestations of Sjögren's syndrome.

S Lehrer1, E Bogursky, M Yemini, N G Kase, A Birkenfeld.   

Abstract

OBJECTIVE: Sjögren's syndrome is a chronic, inflammatory autoimmune disease in which the salivary and lacrimal glands are progressively destroyed by lymphocytes and plasma cells. Because women are affected 10 times more often than men, we studied gynecologic manifestations of Sjögren's syndrome. STUDY
DESIGN: One thousand questionnaires were sent to women with Sjögren's syndrome in New York, New Jersey, Connecticut, and Pennsylvania. Five hundred thirty-nine women responded.
RESULTS: Women with Sjögren's syndrome reported significant vaginal dryness. There was no relationship of Sjögren's syndrome to either the incidence of infertility or miscarriage, although the 4% incidence of congenital anomalies in offspring was relatively high. Of the congenital anomalies, nine of 19 (47%) were cardiac. A long menstrual cycle (> 35 days) was associated with infertility and neuropathy.
CONCLUSIONS: The vaginal dryness in women with Sjögren's syndrome is not surprising, because the nasal and esophageal mucosae are also dry in this disorder. The relationship of infertility to a long menstrual cycle may simply indicate the presence of ovulatory dysfunction or inadequate luteal phase unrelated to Sjögren's syndrome. The relationship of neuropathy to a long menstrual cycle may be related to repeated, prolonged estrogen or progesterone exposure during the long cycles or to involvement of hypothalamic-pituitary-ovarian function.

Entities:  

Mesh:

Year:  1994        PMID: 8141212     DOI: 10.1016/s0002-9378(94)70294-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Ocular surface wetness is regulated by TRPM8-dependent cold thermoreceptors of the cornea.

Authors:  Andrés Parra; Rodolfo Madrid; Diego Echevarria; Susana del Olmo; Cruz Morenilla-Palao; M Carmen Acosta; Juana Gallar; Ajay Dhaka; Félix Viana; Carlos Belmonte
Journal:  Nat Med       Date:  2010-11-14       Impact factor: 53.440

Review 2.  Myelopathy in Sjögren's syndrome: role of nonsteroidal immunosuppressants.

Authors:  Susan J Rogers; Christopher S Williams; Gustavo C Román
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Menopausal hormone therapy in women with medical conditions.

Authors:  Ekta Kapoor; Juliana M Kling; Angie S Lobo; Stephanie S Faubion
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2021-09-10       Impact factor: 4.690

4.  2021 recommendations of the Brazilian Society of Rheumatology for the gynecological and obstetric care of patients with Sjogren's syndrome.

Authors:  Fabiola Reis Oliveira; Valeria Valim; Sandra Gofinet Pasoto; Marilena Leal Mesquita Silvestre Fernandes; Maria Lucia Lemos Lopes; Sonia Cristina de Magalhães Souza Fialho; Aysa César Pinheiro; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lucia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Libório; Maria Carmen Lopes Ferreira Silva Santos; Leandro Tanure; Juliana DAgostino Gennari; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; César Ramos Rocha-Filho; Samira Tatiyama Miyamoto; Lissiane Karine Noronha Guedes; Alisson Pugliesi; Virginia Fernandes Moça Trevisani
Journal:  Adv Rheumatol       Date:  2021-09-03

Review 5.  Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment.

Authors:  Tim Both; Virgil A S H Dalm; P Martin van Hagen; Paul L A van Daele
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

Review 6.  Advances in the Aetiophatogenesis of Sjögren's Syndrome: a Literature Review.

Authors:  Pedro de Sousa Gomes; Gintaras Juodzbalys; Maria Helena Fernandes; Zygimantas Guobis
Journal:  J Oral Maxillofac Res       Date:  2012-04-01

7.  Primary Sjögren's Syndrome Adversely Affects the Female Sexual Function Assessed by the Female Sexual Function Index: A Case-Control Study.

Authors:  Çağlar Yildiz; Savaş Karakuş; Özlem Bozoklu Akkar; Ali Şahin; Birkan Bozkurt; Ali Yanik
Journal:  Arch Rheumatol       Date:  2017-02-12       Impact factor: 1.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.